Ongoing testing is focused on evaluating the safety and composition of the seized products
GLP-1R agonists (e.g., exendin-4 and liraglutide) reduce APP expression and processing in the brains of AD model mice through the activation of GLP-1R, decrease A protein production and plaque aggregation, and thus improve their spatial memory capacity (McClean et al., 2015
Piskin E, Cianciosi D, Gulec S, Tomas M, Capanoglu EA
EVs are typically classified as small EV fractions (s-EVs) and large EV fractions (l-EVs) based on their sedimentation properties, despite substantial size and content overlaps
Now a major meta analysis of randomized placebo-controlled trials has concluded that GLP-1 agonists probably have little or no effect on the risk of obesity-related cancers such as breast cancer
Patients and clinicians should watch for sudden vision changes and seek advice quickly